Ho, Nicola Gabrielle (2022) The fate of FTC v. Actavis, Inc. in the biosimilar context - does and should the FTC v. Actavis decision apply to reverse patent settlements between brand drug and biosimilar manufacturers? Biotechnology Law Report, 41 (4). 194 - 199. ISSN 0730-031X
Full text not available from this repository.
Identification Number: 10.1089/blr.2022.29274.nho
| Item Type: | Article |
|---|---|
| Official URL: | https://home.liebertpub.com/publications/biotechno... |
| Additional Information: | © 2022 Mary Ann Liebert, Inc. |
| Divisions: | LSE |
| Subjects: | R Medicine > RA Public aspects of medicine > RA1001 Forensic Medicine. Medical jurisprudence. Legal medicine |
| Date Deposited: | 13 Sep 2022 09:33 |
| Last Modified: | 26 Oct 2024 18:09 |
| URI: | http://eprints.lse.ac.uk/id/eprint/116601 |
Actions (login required)
 |
View Item |
